Intera Atlas
Run match
Sites / Velocity Clinical Research
Is this you?

Request access for Velocity Clinical Research with your @velocityclinical.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Velocity Clinical Research

Unclaimed profile

Hybrid · Durham, NC · ~~80 sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 9Lift (cardio sample) 0.12Recruit soph 0.57
Quality Scorecard (1–100)
Overall84Recruit85Ops79Sponsor91Ther81

Performance (observed)

Historical trials
744
Completed
394
Terminated/Withdrawn
58
Completion rate
87%
Active now
286
Phase 2
265
Phase 3
401
Realized enrollment
1,203,703
First study year
2016
Years active
10
Match confidence
high
Enrollment velocity (inf)
120,370

Therapeutic

Areas
Multi-specialty (inherits Meridian's therapeutic breadth)
Specialties
Multi-specialty; Phase I-IV; 20+ years experience; 1,700+ completed studies
Breadth (conditions)
458
Languages
English + Spanish (detected)
States
25+ US states, Europe

Recruitment (web observed)

Trial Finder
Yes
Patient database
Y
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Strong (VISION platform content, technology focus)
Capability notes
VISION AI platform for intelligent patient recruitment and self-screening; AI-driven trial matching; accelerated prescreening (650% faster vs. traditional); VISION randomized 10K+ patients across 200+ studies; 1.5M+ potential participants in database

Relationships

Sponsors
Eli Lilly and Company; Novo Nordisk A/S; Pfizer; Merck Sharp & Dohme LLC; ModernaTX, Inc.; AbbVie
CROs
Covance; ICON Clinical Research; ICON plc; IQVIA Pty Ltd; Laboratorios Liconsa; Medpace, Inc.
Partnerships
No major public partnerships listed
Owner / parent
$500M total funding; created through acquisition of Meridian (2022); global expansion ongoing
Expansion
Y (600+ employees worldwide; expanding globally)
Recent hiring
Y (Sub Investigator, PI, Coordinator roles active 2024-2026)

Capacity & people

Investigators
—
Coordinators
—
CEO
Paul Evans, PhD
VP Clinical Ops
Unknown
VP Site Ops
Nick Spittal (Chief Operations Officer)
VP Recruitment
Raghu Punnamraju (Chief Technology Officer)

Tech & DCT

eSource
Yes
eConsent
Yes
Uses AI
Yes
Builds tech
Builds tech internally (tech hub in Hyderabad, India)
Home visits
N
DCT / decentralized
Y (60+ sites across U.S. and Europe)
Tech stack
VISION (proprietary AI platform), VISION Recruit, VISION Engage (mobile app), data integration and analytics
Recruiting visible
Y

Notes

Excellent Intera fit: ~80 sites globally (25+ US states). AI-powered VISION platform for recruitment/retention. Builds tech internally (India hub). Recruitment-focused innovation (prescreening automation = 20 FTE equivalent work). 1.5M+ patient database for intelligent matching. Multi-concurrent studies (200+). PE-backed with significant growth capital. Partnership with Privia Health for embedded sites. Advertises patient recruitment services. [Validated: 27 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 0.28Liftability 0.12Overall84

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.